0001209191-17-031377.txt : 20170510 0001209191-17-031377.hdr.sgml : 20170510 20170510171742 ACCESSION NUMBER: 0001209191-17-031377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170510 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 205 EAST 42ND STREET STREET 2: SUITE 15-048 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 205 EAST 42ND STREET STREET 2: SUITE 15-048 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Werber Yaron CENTRAL INDEX KEY: 0001704638 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 17831542 MAIL ADDRESS: STREET 1: C/O OVID THERAPEUTICS INC. STREET 2: 1460 BROADWAY, SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-10 0 0001636651 Ovid Therapeutics Inc. OVID 0001704638 Werber Yaron C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 0 1 0 0 CBO, CFO, Sec. and Treas. Employee Stock Option (Right to Buy) 8.50 2017-05-10 4 A 0 93022 0.00 A 2017-05-10 2027-01-19 Common Stock 93022 93022 D 100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms. Laura Berezin, Attorney-in-Fact 2017-05-10